NASDAQ$BLTE

Belite Bio Inc · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

BLTE Q4 2023 — extraction skipped

Belite Bio Inc filed Form 6-K (accession 0001104659-24-037577) for Q4 2023, but headline financial numerics could not be extracted automatically: no headline numerics found by parser nor by Financial Datasets fallback. The row is marked as AI-processed so the queue advances; numerics will be filled by Financial Datasets on its next pass.

  • Form 6-K filed; press release body not parseable here.
  • Reason: no headline numerics found by parser nor by Financial Datasets fallback.
  • Numerics rely on the Financial Datasets fallback.

Headline financials

Total Revenue

$0.00

No prior period
EPS (adj)

-$0.25

Previous: -$0.63+60.3%
Capital Expenditures

$63K

Previous: $394K-84.0%
Net Income

-$6.99M

Previous: -$6.9M-1.4%
Operating Income

-$6.96M

Previous: -$6.88M-1.1%
Gross Profit

$0.00

No prior period
R&D Expense

$4.86M

No prior period
Stock-Based Comp

$3.82M

Previous: $1.48M+157.8%

Revenue & EPS history

Belite Bio · Revenue · Quarterly

$0

Q4 2023

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 12 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+0.3%

Avg return

Earnings day

+4.6%

Avg return

5 days after

+3.1%

Avg return

30 days after

31%

4 / 13 earnings

Positive

+36.6%

Q2 2022

Best reaction

-15.2%

Q4 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026-6.5%
Q1 2025-3.4%+3.9%+0.2%
Q4 2024+0.5%-0.2%-15.1%
Q3 2024+4.6%+5.3%-19.4%
Q2 2024-1.4%+1.3%-2.1%
Q1 2024-0.1%+6.9%+18.8%
Q4 2023-15.2%-16.5%-13.6%
Q3 2023-3.7%-5.4%+12.3%
Q2 2023+2.3%+4.2%+39.9%
Q4 2022-3.4%-1.2%-1.9%
Q4 2020-3.4%-1.2%-1.9%
Q4 2021-3.4%-1.2%-1.9%
Q2 2022+36.6%+59.4%+21.7%
Q3 2021
Q2 2021
Q1 2021
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro